Cancer Immunoprevention Network Resource Coordinating Center
Official title: Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center
Funded at Roswell Park Cancer Institute Corp · NIH-11401459 · Data updated 2026-11-12
A national center will coordinate data and resources for researchers studying how the immune system can prevent cancer, helping scientists share analyses, standards, and tools.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Roswell Park Cancer Institute Corp NIH-funded |
| Lab location | 1 site (Buffalo, United States) |
| Project start | September 1, 2025 |
| Project end | August 31, 2030 |
| Funding year | 2026 |
| Award (this year) | $798,998 |
| NIH project number | 5U24CA305623-02 |
| Project ID | NIH-11401459 on NIH RePORTER |
Who could benefit from this research
✓Could help
Researchers and clinicians studying cancer immunoprevention, who may later translate findings into patient care.
✕Less likely to help
Patients currently not involved in this center’s activities or who are not part of any immediate clinical trials.
What this research studies
This grant funds a Data and Resource Coordinating Center to connect CIP-Net researchers, manage and harmonize data, and share resources with the wider scientific community. It focuses on building collaborative workflows, improving analytics access, and ensuring data interoperability to speed immunoprevention research. The center will serve as an administrative hub and data backbone so researchers can work together more efficiently toward preclinical strategies that prevent cancer.
Why it matters
Potential benefit: If successful, this center could accelerate discoveries in cancer immunoprevention and make data and tools more available to researchers and clinicians.
How similar studies have gone: Previous data-sharing and coordination centers have shown that improved collaboration and standardized data can accelerate research progress.
Where this research is happening
-
Roswell Park Cancer Institute Corp
Buffalo, United States Active
Researchers
- Principal investigator: Hutson, Alan David — Roswell Park Cancer Institute Corp
- Study coordinator: Hutson, Alan David
Related research
Other NIH-funded projects on the same topics.
-
A network for sharing data and resources in immuno-oncology.
This study is all about bringing together experts to find better ways to treat cancer by understanding why some treatments don’t work and discovering new targets for the immune system, which could lead to more personalized and effective therapies for adults.
-
A network for sharing data and resources in immuno-oncology
This study is all about finding better ways to treat cancer using the body's immune system by working together with different experts to share information, which could lead to new treatments and help patients like you have more effective options.
-
Targeting retrotransposons to help kids with hard-to-treat cancers like neuroblastoma
Aims to repurpose safe antiviral drugs to block retrotransposons in children with relapsed or refractory neuroblastoma to improve outcomes.
-
MedSupport: Helping families overcome barriers to kids' chemotherapy medicines
This program offers extra support to parents of children with acute lymphoblastic leukemia to help them give home chemotherapy medicines more reliably.
-
Innate immune cells and female lung cancer risk
A study exploring how certain immune cells in the lungs may contribute to lung cancer in young women who don’t smoke.
-
Effect of ONP filler materials on how fast nicotine is delivered
This grant tests how different filler materials in oral nicotine pouches affect how quickly nicotine is released and absorbed in the mouth.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.